Inhibition of factor VIII with a partially inhibitory human recombinant monoclonal antibody prevents thrombotic events in a transgenic model of type II HBS antithrombin deficiency in mice - Dewerchin,M.; Van der,E.L.; Singh,I. (J Thromb Haemost, 2004)